Hot or Not, Stock Market Edition: 07/23/2026
BeOne Medicines (ONC) just landed three FDA wins in a row, and all 8 covering analysts call it a Buy — see what's driving it, plus the EV maker failing every single metric we track.
2 months ago•Jessie Moore